Petros F.
- Country
- Greece
- Department
- Outpatient Psychiatric Department
Research Overview
- Long-Term Safety and Tolerability Assessment of Trospium Chloride and Xanomeline Tartrate in Psychosis Associated with Alzheimer's Disease
- Evaluation of KarXT (Trospium Chloride, Xanomeline Tartrate) for Treating Psychosis in Alzheimer's Disease: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 57 of 88 partner sites.
Specializations
Neurodegenerative Disorders
The investigator specializes in studying psychosis associated with Alzheimer's Disease, focusing on innovative therapeutic approaches for managing complex neuropsychiatric symptoms in elderly patients.
- Alzheimer's Disease Complications
- Neuropsychiatric Symptoms
- Geriatric Psychiatry
Their research encompasses the evaluation of novel treatments for hallucinations and delusions in Alzheimer's patients.
Psychiatric Therapeutics
The investigator explores treatment modalities for psychosis in neurodegenerative conditions, with particular attention to the clinical assessment of psychotic symptoms using specialized rating scales.
- Psychosis Management
- Clinical Assessment Tools
- Therapeutic Interventions
Their work involves evaluating the effectiveness of new compounds in treating neuropsychiatric symptoms.
Clinical Assessment
The investigator utilizes specialized clinical measurement tools including the Neuropsychiatric Inventory-Clinician scale to evaluate treatment outcomes in elderly patients with psychosis.
- Psychiatric Evaluation Methods
- Treatment Efficacy Assessment
- Clinical Outcomes Measurement
Their expertise includes the application of standardized assessment tools in clinical research settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.